Ardent Health (NYSE:ARDT) Announces Earnings Results

by · The Markets Daily

Ardent Health (NYSE:ARDT – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.08, FiscalAI reports. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The business had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.60 billion.

Ardent Health Stock Up 10.7%

NYSE:ARDT traded up $1.26 during trading hours on Wednesday, reaching $12.97. The company had a trading volume of 1,076,331 shares, compared to its average volume of 454,994. Ardent Health has a twelve month low of $7.71 and a twelve month high of $14.82. The firm has a market cap of $1.83 billion, a price-to-earnings ratio of 23.57, a P/E/G ratio of 3.32 and a beta of 0.58. The business’s 50-day simple moving average is $11.19 and its two-hundred day simple moving average is $10.00. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on ARDT shares. Weiss Ratings raised Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, October 6th. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Monday, September 7th. BMO Capital Markets assumed coverage on Ardent Health in a research note on Tuesday, September 22nd. They set a “market perform” rating and a $11.00 target price for the company. Truist Financial lifted their target price on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Finally, Leerink Partners reissued an “outperform” rating and issued a $14.00 price target on shares of Ardent Health in a research note on Friday, September 18th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $12.79.

View Our Latest Analysis on Ardent Health

About Ardent Health

(Get Free Report)

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.

See Also